Biotechnology Assets, S.A. (BME:BST)

Spain · Delayed Price · Currency is EUR

0.2100

+0.0100 (5.00%)

Jul 17, 2026, 5:35 PM CET

-48.53% (1Y)

Market Cap	15.60M -43.8%
Revenue (ttm)	3.43M -4.9%
Net Income	-1.92M
EPS	n/a
Shares Out	74.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1940
Previous Close	0.2000
Day's Range	0.1910 - 0.2150
52-Week Range	0.1760 - 0.4750
Beta	1.83
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 21, 2026

About Biotechnology Assets

Biotechnology Assets, S.A. develops and markets biotechnological assets for applications in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a protein engineering tool that allows the conjugation of proteins through the formation of new peptide bonds; universal switchable split-chimeric antigen receptor (CAR); VACC-ZERA technology, a tool to generate recombinant proteins in microparticles suited for therapeutic and prophylactic adjuvant free vaccines administer... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1954

Employees 26

Stock Exchange Madrid Stock Exchange

Ticker Symbol BST

Full Company Profile

Financial Performance

In 2025, Biotechnology Assets's revenue was 3.43 million, a decrease of -4.88% compared to the previous year's 3.61 million. Losses were -1.92 million, -34.32% less than in 2024.

Financial Statements